Nesta página
01DVA preço
02Instantâneo
03Gráfico
04Divisões de Ações
05Sobre
06Desempenho
07Avaliação e rácios
13Dividendos
14Lucros
15Fundamentos Completos
16Demonstrações
17Investidores institucionais (13F)
18Ativistas e proprietários de 5%+
19Executivos da empresa
20Participação em ETFs
21Consenso
22Pares
25Sinais de trading
26Minhas Métricas
DVA DaVita Inc. Common Stock
NYSE · Health Care · Ver em SEC EDGAR ↗ fechar Out 2, 2026 10-K/10-Q Ago 4, 2026
$178,69
· % da faixa de 52 semanas
· acima do mínimo
· para alta
$101,00mínima 52 sem
$247,49máxima 52 sem
Capitalização de Mercado (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
Receita (TTM)
$14.01B
seus distintivos
Intervalo 52 Semanas
$101–$247
Classificação do Analista
BUY
Preço-Alvo
$220
P/E
14.7
ROE
-149.4%
Margem de Lucro Líquido
6.0%
Sua barra de distintivos está vazia — fixe uma métrica em qualquer lugar desta página.
DVA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$178.69
Capitalização de Mercado (MRQ)
$11.43B
P/E (TTM)
14.7
EPS (TTM)
$12.15
Receita (TTM)
$14.01B
Rendimento div.
0.00%
ROE (TTM)
-149.4%
Intervalo 52 Semanas
$101–$247
DVA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
intervalo
barras
A granularidade da barra se adapta ao período selecionado — passe o mouse sobre o gráfico para ver a abertura/máxima/mínima/fechamento de uma barra.
Divisões de Ações
| Data ex | Desdobramento | Tipo |
|---|---|---|
| 9 de Setembro de 2013 | 2-for-1 | Para frente |
| 16 de Junho de 2004 | 3-for-2 | Para frente |
| 21 de Outubro de 1997 | 5-for-3 | Para frente |
Sobre DaVita Inc. Common Stock Visão geral da empresa da Wikipedia
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
## History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
setorHealth Care
indústriaHealth Care
funcionários78.000
paísUS
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita$13.64B2016-12-31 → 2025-12-31
EPS$9.842016-12-31 → 2025-12-31
Fluxo de caixa livre$1.31B2016-12-31 → 2025-12-31
Margem líquida6.0%2018-12-31 → 2025-12-31
Avaliação e Proporções
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
| Métrica | Tendência de 5 anos | DVA | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| P/E (TTM) | 14.7média 5A ≈13.0 | ≈13.0 | 23.4 | Subvalorizado | |
| P/S (TTM) | 0.8média 5A ≈0.8 | ≈0.8 | 1.8 | Subvalorizado | |
| P/B (MRQ) | -14.9média 5A ≈24.1 | ≈24.1 | · | · | |
| Preço / FCF (TTM) | 7.1média 5A ≈7.2 | ≈7.2 | · | · | |
| Preço / Fluxo de Caixa (TTM) | 5.2média 5A ≈4.9 | ≈4.9 | 11.3 | Subvalorizado | |
| Preço / Valor Patrimonial Tangível (MRQ) | -11.5 | · | · | · | |
| PEG Ratio | ≈1.6 | · | · | · |
A mediana dos pares é calculada em uma base padronizada por métrica e pode não corresponder sempre à base TTM/MRQ mostrada para esta ação.
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
| Métrica | Tendência de 5 anos | DVA | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Margem Operacional (TTM) | 15.2%média 5A ≈14.3% | ≈14.3% | 9.2% | Primeira linha | |
| Margem EBITDA (TTM) | 20.2%média 5A ≈20.1% | ≈20.1% | 12.7% | Primeira linha | |
| Margem de Impostos Pré-Tributação (TTM) | 10.5%média 5A ≈10.6% | ≈10.6% | 4.3% | Primeira linha | |
| Margem de Lucro Líquido (TTM) | 6.0%média 5A ≈6.3% | ≈6.3% | 5.1% | Primeira linha | |
| ROA (TTM) | 4.8%média 5A ≈4.6% | ≈4.6% | 3.7% | Primeira linha | |
| ROE (TTM) | -149.4%média 5A ≈24.7% | ≈24.7% | 10.5% | Fraco | |
| ROIC | -245.6%média 5A ≈325.5% | ≈325.5% | 5.1% | Fraco |
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
| Métrica | Tendência de 5 anos | DVA | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Índice de liquidez corrente (MRQ) | 1.5média 5A ≈1.3 | ≈1.3 | 1.5 | Em linha | |
| Índice de Liquidez Seca (MRQ) | 1.1média 5A ≈1.0 | ≈1.0 | 1.0 | Em linha |
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
| Métrica | Tendência de 5 anos | DVA | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Revenue YoY (Receita Ano a Ano) | 6.5%média 5A ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y (CAGR Receita 3A) | 5.5%média 5A ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (CAGR Receita 5A) | 3.4% | · | · | · | |
| EPS YoY | -8.3%média 5A ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY (Lucro Líquido Ano a Ano) | -20.2%média 5A ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y (CAGR de LPA 3A) | 18.9%média 5A ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y (CAGR de LPA 5A) | 9.3% | · | · | · | |
| Net Income CAGR 3Y (CAGR de Lucro Líquido 3A) | 10.0%média 5A ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (CAGR de Lucro Líquido 5A) | -0.70% | · | · | · |
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
| Métrica | Tendência de 5 anos | DVA | média 5A | Mediana de Pares | Veredito |
|---|---|---|---|---|---|
| Asset Turnover (Giro do Ativo) | 0.8média 5A ≈0.7 | ≈0.7 | 0.8 | Em linha | |
| Receivables Turnover (Giro de Contas a Receber) | 6.0média 5A ≈6.0 | ≈6.0 | 10.6 | Fraco | |
| Revenue / Employee (Receita anual ÷ funcionários (número de funcionários reportado, yfinance). Derivado — não é um conceito SEC-XBRL armazenado.) | ≈$174.9K | · | · | · |
valor · ≈ média 5A · mediana do setor · veredicto relativo à mediana
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
Dividend Yield0.00%
Índice de Pagamento0.00%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.05%
Próximo relatório
Out 27, 2026
| Período | Relatório | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|---|
| 30 de Junho de 2026 | Ago 3, 2026 | $4.02 | $3.92 | 2.5% |
| 31 de Março de 2026 | Mai 11, 2026 | $2.87 | $2.34 | 22.6% |
| 31 de Dezembro de 2025 | $3.40 | $3.19 | 6.7% | |
| 30 de Setembro de 2025 | $2.04 | $3.25 | -37.3% | |
| 30 de Junho de 2025 | $2.95 | $2.83 | 4.2% | |
| 31 de Março de 2025 | $2.00 | $1.97 | 1.7% |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Balanço Patrimonial
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Fluxo de Caixa
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Lucratividade
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidez e Solvência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Eficiência
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Por Ação
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
Taxas de Crescimento
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Avaliação (TTM)
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Demonstração de Resultados
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Balanço Patrimonial
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Fluxo de Caixa
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Lucratividade
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidez e Solvência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Eficiência
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Por Ação
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
Avaliação (TTM)
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
Período mais recente à esquerda · valores nulos mostrados como ·
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Receita | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Margem Operacional % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Lucro líquido | $747M | $936M | $692M | $560M | $978M |
| EPS Diluído | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Índice de liquidez corrente | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Índice de Liquidez Seca | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Investidores institucionais (13F) 692 declarantes · $13.6B total · Em 30 de Setembro de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Detentores
692
Valor detido
$13.6B
Novas posições
126
Posições encerradas
61
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 126 (-14 vs trimestre anterior) | 61 (-2 vs trimestre anterior) | 195 (+23 vs trimestre anterior) | 226 (+12 vs trimestre anterior) | -1.1M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6.425.268.898 | 28.880.209 | 47,23% | Ações |
| BlackRock, Inc. | $547.520.494 | 2.460.987 | 4,02% | Ações |
| VANGUARD GROUP INC | $471.976.159 | 4.154.354 | 3,47% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $467.525.034 | 2.101.425 | 3,44% | Ações |
| MORGAN STANLEY | $356.348.822 | 1.601.710 | 2,62% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306.558.307 | 1.377.914 | 2,25% | Ações |
| STATE STREET CORP | $294.345.267 | 1.323.019 | 2,16% | Ações |
| Invesco Ltd. | $269.627.293 | 1.211.917 | 1,98% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $253.130.449 | 1.137.814 | 1,86% | Ações |
| NEUBERGER BERMAN GROUP LLC | $205.758.498 | 925.579 | 1,51% | Ações |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197.802.963 | 889.082 | 1,45% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $189.562.167 | 853.602 | 1,39% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163.166.832 | 733.400 | 1,20% | Opção de compra |
| Gates Capital Management, Inc. | $153.096.497 | 688.136 | 1,13% | Ações |
| BANK OF AMERICA CORP /DE/ | $145.056.737 | 651.999 | 1,07% | Ações |
| D. E. Shaw & Co., Inc. | $142.571.191 | 640.827 | 1,05% | Ações |
| AQR CAPITAL MANAGEMENT LLC | $128.131.338 | 587.758 | 0,94% | Ações |
| GOLDMAN SACHS GROUP INC | $103.093.004 | 463.381 | 0,76% | Ações |
| Bank of New York Mellon Corp | $101.127.189 | 454.545 | 0,74% | Ações |
| NORDEA INVESTMENT MANAGEMENT AB | $87.427.043 | 395.687 | 0,64% | Ações |
| NORTHERN TRUST CORP | $84.995.593 | 382.037 | 0,62% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81.331.791 | 365.569 | 0,60% | Ações |
| NORGES BANK | $76.627.007 | 344.422 | 0,56% | Ações |
| UBS Group AG | $67.900.673 | 305.199 | 0,50% | Ações |
| JANE STREET GROUP, LLC | $62.548.028 | 281.140 | 0,46% | Ações |
| JANE STREET GROUP, LLC | $53.573.184 | 240.800 | 0,39% | Opção de compra |
| Holocene Advisors, LP | $52.875.709 | 237.665 | 0,39% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.100.176 | 216.200 | 0,35% | Opção de venda |
| ROYAL BANK OF CANADA | $47.787.000 | 214.787 | 0,35% | Ações |
| DEUTSCHE BANK AG\ | $46.356.378 | 208.362 | 0,34% | Ações |
| Quantinno Capital Management LP | $45.366.106 | 203.910 | 0,33% | Ações |
| JPMORGAN CHASE & CO | $44.467.785 | 200.781 | 0,33% | Ações |
| CITADEL ADVISORS LLC | $44.465.298 | 199.862 | 0,33% | Ações |
| CITADEL ADVISORS LLC | $44.184.528 | 198.600 | 0,32% | Opção de compra |
| BARCLAYS PLC | $43.410.740 | 195.122 | 0,32% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $40.134.502 | 180.396 | 0,30% | Ações |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37.089.700 | 241.328 | 0,27% | Ações |
| Gotham Asset Management, LLC | $36.393.278 | 163.580 | 0,27% | Ações |
| JANE STREET GROUP, LLC | $35.774.784 | 160.800 | 0,26% | Opção de venda |
| Doma Perpetual Capital Management LLC | $35.522.937 | 159.668 | 0,26% | Ações |
| FIRST TRUST ADVISORS LP | $34.161.205 | 153.548 | 0,25% | Ações |
| TODD ASSET MANAGEMENT LLC | $32.697.663 | 146.969 | 0,24% | Ações |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32.011.312 | 143.884 | 0,24% | Ações |
| Allianz Asset Management GmbH | $30.236.367 | 135.906 | 0,22% | Ações |
| Toroso Investments, LLC | $29.297.520 | 257.878 | 0,22% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $26.480.460 | 119.024 | 0,19% | Ações |
| VICTORY CAPITAL MANAGEMENT INC | $26.377.896 | 118.563 | 0,19% | Ações |
| Amundi | $25.967.198 | 116.717 | 0,19% | Ações |
| FMR LLC | $25.475.535 | 114.507 | 0,19% | Ações |
| Davidson Kempner Capital Management LP | $25.162.043 | 113.098 | 0,18% | Ações |
Ativistas e proprietários de 5%+ 1 participação
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 declarações | 13 de Fevereiro de 2025 | 45,00% | Emenda | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Executivos da empresa 59 insiders · 31 diretores · 25 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 de Junho de 2026 S | 840.408 | 0 | 2 | $-14.532.097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 de Maio de 2016 S | 18.766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7 de Maio de 2026 S | 132.434 | 0 | 1 | $-9.887.579 |
| Luis Borgen | Chief Financial Officer | 22 de Março de 2012 M | 18.517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 de Março de 2010 A | 33.604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 de Março de 2007 A | 31.250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1 de Julho de 2006 A | 10.000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 22 de Setembro de 2026 F | 86.604 | 0 | 2 | $-4.089.696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 de Agosto de 2024 S | 209.365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 de Dezembro de 2016 A | 4.688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 de Junho de 2026 S | 109.194 | 0 | 2 | $-3.210.360 |
| James O Hearty | Chief Compliance Officer | 14 de Maio de 2026 M | 22.389 | 0 | 2 | $-3.291.616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 de Março de 2026 A | 19.640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 de Março de 2023 F | 15.676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 de Setembro de 2020 M | 24.590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1 de Junho de 2020 F | 110.462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2 de Junho de 2019 F | 33.125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 de Junho de 2017 M | 3.514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 de Setembro de 2015 M | 7.438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4 de Junho de 2015 S | 2.322.928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 de Fevereiro de 2014 M | 8.990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9 de Setembro de 2013 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2 de Agosto de 2013 G | 2.315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 de Fevereiro de 2012 M | 17.491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 de Junho de 2009 M | 5.547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 de Fevereiro de 2009 M | 2.084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 de Agosto de 2008 M | 2.500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5 de Março de 2008 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 de Julho de 2007 A | 6.250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8 de Maio de 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4 de Novembro de 2005 M | 42.000 | 0 | 0 | $0 |
| Dennis W Pullin | Conselheiro | 15 de Agosto de 2026 A | 2.949 | 0 | 0 | $0 |
| Gregory J. Moore | Conselheiro | 15 de Agosto de 2026 A | 8.091 | 0 | 0 | $0 |
| Jason M. Hollar | Conselheiro | 15 de Agosto de 2026 A | 6.883 | 0 | 0 | $0 |
| Patricia M Arway | Conselheiro | 15 de Agosto de 2026 A | 27.223 | 0 | 0 | $0 |
| Adam H Schechter | Conselheiro | 15 de Agosto de 2026 A | 5.970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Conselheiro | 15 de Agosto de 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Conselheiro | 15 de Agosto de 2026 A | 9.803 | 0 | 0 | $0 |
| Barbara J Desoer | Conselheiro | 15 de Agosto de 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Conselheiro | 15 de Maio de 2025 A | 19.982 | 0 | 0 | $0 |
| John M Nehra | Conselheiro | 15 de Maio de 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Conselheiro | 15 de Maio de 2023 A | 16.069 | 0 | 0 | $0 |
| Paula A Price | Conselheiro | 15 de Maio de 2022 A | 1.395 | 0 | 0 | $0 |
| Shawn M Guertin | Conselheiro | 15 de Maio de 2021 A | 1.105 | 0 | 0 | $0 |
| Pascal Desroches | Conselheiro | 15 de Novembro de 2020 A | 8.030 | 0 | 0 | $0 |
| William L Roper | Conselheiro | 11 de Junho de 2020 A | 16.234 | 0 | 0 | $0 |
| Peter T Grauer | Conselheiro | 11 de Junho de 2020 A | 76.204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Conselheiro | 31 de Dezembro de 2017 A | 10.764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Conselheiro | 11 de Junho de 2012 A | 7.195 | 0 | 0 | $0 |
| Richard C Vaughan | Conselheiro | 13 de Maio de 2010 A | 6.092 | 0 | 0 | $0 |
| Nancy Ann Deparle | Conselheiro | 30 de Junho de 2008 A | 3.256 | 0 | 0 | $0 |
| Raymond C Larkin JR | Conselheiro | 31 de Março de 2007 A | 8.684 | 0 | 0 | $0 |
| Michele J Hooper | Conselheiro | 13 de Maio de 2005 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | 17 de Setembro de 2020 S | 1.991.806 | 0 | 0 | $0 |
| Roger Valine | · | 30 de Junho de 2017 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | 17 de Dezembro de 2015 M | 8.447 | 0 | 0 | $0 |
| Richard B Fontaine | · | 16 de Maio de 2007 G | 10.000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | 25 de Fevereiro de 2005 M | 3.000 | 0 | 0 | $0 |
| Patrick A Broderick | · | 5 de Maio de 2004 M | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 97 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5,19% | 213.947 NS | 31 de Julho de 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 3,36% | 13.006 NS | 31 de Julho de 2026 | N-PORT |
| AZTD · Tidal Trust I | 3,06% | 4.824 NS | 31 de Julho de 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,44% | 106.663 NS | 31 de Julho de 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,59% | 78.593 SH | 2 de Outubro de 2026 | Diário |
| AMOM · Exchange Listed Funds Trust | 1,41% | 1.399 NS | 31 de Julho de 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,19% | 760 NS | 31 de Julho de 2026 | N-PORT |
| IHF · iShares Trust | 0,85% | 61.700 SH | 11 de Setembro de 2026 | Diário |
| JMID · Janus Detroit Street Trust | 0,46% | 456 NS | 31 de Julho de 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,46% | 8.917 NS | 31 de Julho de 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,34% | 4.688 NS | 31 de Julho de 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 6.488 NS | 31 de Julho de 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9.914 SH | 19 de Agosto de 2026 | Diário |
| ROSC · Lattice Strategies Trust | 0,27% | 691 NS | 31 de Julho de 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22.513 SH | 2 de Outubro de 2026 | Diário |
| BKMC · BNY Mellon ETF Trust | 0,22% | 5.948 NS | 31 de Julho de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,20% | 126.925 NS | 31 de Julho de 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1.066.571 SH | 2 de Outubro de 2026 | Diário |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 15.260 NS | 31 de Julho de 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 1.456 NS | 31 de Julho de 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467.367 SH | 19 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 15.871 NS | 31 de Julho de 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 6.102 SH | 11 de Setembro de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,11% | 100.394 SH | 19 de Agosto de 2026 | Diário |
| ESML · iShares Trust | 0,10% | 16.178 SH | 11 de Setembro de 2026 | Diário |
| IYH · iShares Trust | 0,09% | 18.805 SH | 11 de Setembro de 2026 | Diário |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 4.169 SH | 2 de Outubro de 2026 | Diário |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736.199 SH | 19 de Agosto de 2026 | Diário |
| CURE · Direxion Shares ETF Trust | 0,09% | 632 NS | 31 de Julho de 2026 | N-PORT |
| SMMD · iShares Trust | 0,08% | 17.274 SH | 11 de Setembro de 2026 | Diário |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 4.629 NS | 31 de Julho de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 7.288 NS | 31 de Julho de 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16.934 SH | 11 de Setembro de 2026 | Diário |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 38.130 SH | 2 de Outubro de 2026 | Diário |
| DFAC · Dimensional ETF Trust | 0,06% | 121.442 NS | 31 de Julho de 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3.250 SH | 2 de Outubro de 2026 | Diário |
| DUHP · Dimensional ETF Trust | 0,06% | 29.605 NS | 31 de Julho de 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2.005 SH | 10 de Setembro de 2026 | Diário |
| IWS · iShares Trust | 0,05% | 45.297 SH | 11 de Setembro de 2026 | Diário |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,05% | 322 NS | 31 de Julho de 2026 | N-PORT |
| IWR · iShares Trust | 0,04% | 131.978 SH | 11 de Setembro de 2026 | Diário |
| DCOR · Dimensional ETF Trust | 0,04% | 5.974 NS | 31 de Julho de 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 1.967 NS | 31 de Julho de 2026 | N-PORT |
| XOEF · iShares Trust | 0,04% | 43 SH | 10 de Setembro de 2026 | Diário |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15.586 SH | 2 de Outubro de 2026 | Diário |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,03% | 34.460 SH | 2 de Outubro de 2026 | Diário |
| DFAU · Dimensional ETF Trust | 0,03% | 13.203 NS | 31 de Julho de 2026 | N-PORT |
| CHRI · Global X Funds | 0,02% | 8 NS | 31 de Julho de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2.124 NS | 31 de Julho de 2026 | N-PORT |
| EGLE · Global X Funds | 0,02% | 2 NS | 31 de Julho de 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,02% | 7.420 SH | 19 de Agosto de 2026 | Diário |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 18.428 SH | 19 de Agosto de 2026 | Diário |
| IVE · iShares Trust | 0,02% | 53.283 SH | 11 de Setembro de 2026 | Diário |
| IUSV · iShares Trust | 0,02% | 27.948 SH | 11 de Setembro de 2026 | Diário |
| NEAR · iShares U.S. ETF Trust | 0,02% | 949.000 SH | 9 de Setembro de 2026 | Diário |
| DSI · iShares Trust | 0,02% | 4.810 SH | 11 de Setembro de 2026 | Diário |
| IWD · iShares Trust | 0,01% | 67.699 SH | 11 de Setembro de 2026 | Diário |
| XRMI · Global X Funds | 0,01% | 30 NS | 31 de Julho de 2026 | N-PORT |
| XYLD · Global X Funds | 0,01% | 1.746 NS | 31 de Julho de 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 1.706 NS | 31 de Julho de 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 27.844 SH | 11 de Setembro de 2026 | Diário |
| XYLG · Global X Funds | 0,01% | 32 NS | 31 de Julho de 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 121 NS | 31 de Julho de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 9.492 NS | 31 de Julho de 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,01% | 766 NS | 31 de Julho de 2026 | N-PORT |
| TOPC · iShares Trust | 0,01% | 19 SH | 10 de Setembro de 2026 | Diário |
| XVV · iShares Trust | 0,01% | 377 SH | 10 de Setembro de 2026 | Diário |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 832.243 SH | 19 de Agosto de 2026 | Diário |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.019.458 SH | 19 de Agosto de 2026 | Diário |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 28.136 SH | 19 de Agosto de 2026 | Diário |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.315 SH | 19 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 2.714 SH | 19 de Agosto de 2026 | Diário |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7.283 SH | 19 de Agosto de 2026 | Diário |
| XTR · Global X Funds | 0,01% | 2 NS | 31 de Julho de 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,01% | 225 NS | 31 de Julho de 2026 | N-PORT |
| IWP · iShares Trust | 0,01% | 9.703 SH | 11 de Setembro de 2026 | Diário |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 203 SH | 30 de Setembro de 2026 | Diário |
| SPXL · Direxion Shares ETF Trust | 0,01% | 2.512 NS | 31 de Julho de 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 404.382 SH | 11 de Setembro de 2026 | Diário |
| IWB · iShares Trust | 0,01% | 22.249 SH | 11 de Setembro de 2026 | Diário |
| IYY · iShares Trust | 0,01% | 1.374 SH | 10 de Setembro de 2026 | Diário |
| IWV · iShares Trust | 0,01% | 8.841 SH | 10 de Setembro de 2026 | Diário |
| ITOT · iShares Trust | 0,01% | 41.624 SH | 11 de Setembro de 2026 | Diário |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 24 SH | 30 de Setembro de 2026 | Diário |
| XCLR · Global X Funds | 0,01% | 1 NS | 31 de Julho de 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.542 SH | 2 de Outubro de 2026 | Diário |
| IWF · iShares Trust | 0,00% | 6.443 SH | 2 de Setembro de 2026 | Diário |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 7.000 | 30 de Setembro de 2026 | Diário |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.838 SH | 19 de Agosto de 2026 | Diário |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 de Julho de 2026 | Diário |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 de Julho de 2026 | Diário |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15 de Julho de 2026 | Diário |
| ISCB · iShares Trust | · | 1.571 SH | 11 de Setembro de 2026 | Diário |
| ISCV · iShares Trust | · | 3.661 SH | 11 de Setembro de 2026 | Diário |
| SMLF · iShares Trust | · | 5.973 SH | 11 de Setembro de 2026 | Diário |
| SMMV · iShares Trust | · | 1.837 SH | 1 de Setembro de 2026 | Diário |
DVA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
classificação · 13 analistas
COMPRA
Alvo mediano
$220.00
+23,1%
1 7,7%
Compra forte
6 46,2%
Compra
5 38,5%
Manter
1 7,7%
Venda
0 0,0%
Venda forte
Preço-alvo de 12 meses
7 analistas · 2026-10-04Alvo médio $219.86 +23,0%
Agora
Preço atual $178.69
Mín$165.00
Média$219.86
Máx$270.00
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
Base do ano fiscal, preços no fechamento do último ano fiscal de cada empresa.
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Sinais de trading Sinais recentes de compra/venda com preço de entrada e relação risco/recompensa
BLUECHIP_DIP
Stop out
risco 1
recompensa 2,08
entrada
$179.50
R:R 2,08
BLUECHIP_DIP
Expirado
risco 1
recompensa 2,08
entrada
$176.69
R:R 2,08
Nenhum sinal aberto no momento — nenhum cartão está preenchido, e isso é honesto.
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para si — clique no + ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Fonte: SEC 10-Q arquivado Ago 4, 2026